Loading
Life sciences · Journal article
Scientific Reports · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Total neoadjuvant therapy (TNT), including fractionated external-beam radiotherapy (EBRT), may alter the gut microbiome, yet treatment-associated temporal patterns remain incompletely characterised in rectal cancer (RC). Thirteen patients with locally advanced RC were prospectively followed during the chemoradiotherapy component of TNT, with faecal samples collected before treatment (Fx0), midway through radiotherapy (Fx14), and immediately after the final fraction (Fx28). Aggregate relative frequency was lower in patients than in controls and declined across treatment, whereas Shannon diversity followed a V-shaped pattern, decreasing at Fx14 and increasing again at Fx28. Low-abundance taxa accounted for most detected species despite contributing only a small proportion of cumulative relative abundance. The relative bacterial signal declined transiently at Fx14, accompanied by an increased proportional representation of eukaryotic reads. The rectal cancer-associated taxon Fusobacterium nucleatum declined by Fx28, while the relative representation of SCFA-associated taxa shifted toward acetate-associated and away from butyrate-associated groups, particularly in samples from patients with diarrhoea. Resistome composition also changed over time, with Bacteroides fragilis identified as a prominent inferred ARG carrier. Among the three sampled time points, Fx14 showed the greatest concurrent deviation across several microbiome features, suggesting that mid-treatment may represent a period of increased ecological instability.